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Abstract. 
 
Synaptotagmins (Syts) are transmembrane 
 
proteins with two Ca
 
2
 
1
 
-binding C
 
2 
 
domains in their cy-
tosolic region. Syt I, the most widely studied isoform, 
has been proposed to function as a Ca
 
2
 
1
 
 sensor in syn-
aptic vesicle exocytosis. Several of the twelve known 
Syts are expressed primarily in brain, while a few are 
 
ubiquitous (Sudhof, T.C., and J. Rizo. 1996. 
 
Neuron.
 
17: 379–388; Butz, S., R. Fernandez-Chacon, F. Schmitz, 
R. Jahn, and T.C. Sudhof. 1999. 
 
J
 
.
 
 Biol
 
.
 
 Chem
 
. 274:
18290–18296). The ubiquitously expressed Syt VII 
binds syntaxin at free Ca
 
2
 
1
 
 concentrations ([Ca
 
2
 
1
 
]) be-
 
low 10 
 
m
 
M, whereas other isoforms require 200–500 
 
m
 
M [Ca
 
2
 
1
 
] or show no Ca
 
2
 
1
 
-dependent syntaxin bind-
ing (Li, C., B. Ullrich, Z. Zhang, R.G.W. Anderson, N. 
Brose, and T.C. Sudhof. 1995.
 
 Nature.
 
 375:594–599). We 
investigated the involvement of Syt VII in the exocyto-
sis of lysosomes, which is triggered in several cell types 
at 1–5 
 
m
 
M [Ca
 
2
 
1
 
] (Rodríguez, A., P. Webster, J. Ortego, 
and N.W. Andrews. 1997. 
 
J
 
.
 
 Cell Biol
 
. 137:93–104). 
Here, we show that Syt VII is localized on dense lyso-
somes in normal rat kidney (NRK) ﬁbroblasts, and that 
GFP-tagged Syt VII is targeted to lysosomes after 
transfection. Recombinant fragments containing the 
C
 
2
 
A domain of Syt VII inhibit Ca
 
2
 
1
 
-triggered secretion 
of 
 
b
 
-hexosaminidase and surface translocation of 
Lgp120, whereas the C
 
2
 
A domain of the neuronal-
speciﬁc isoform, Syt I, has no effect. Antibodies against 
the Syt VII C
 
2
 
A domain are also inhibitory in both as-
says, indicating that Syt VII plays a key role in the regu-
lation of Ca
 
2
 
1
 
-dependent lysosome exocytosis.
Key words: calcium-regulated • calcium sensor
• lysosome • secretion • 
 
b
 
-hexosaminidase
 
Introduction
 
Recent studies revealed the existence of a large compo-
 
nent of Ca
 
2
 
1
 
-regulated exocytosis in cells previously
thought to exhibit only constitutive secretion, such as
CHO and other fibroblast lines (Chavez et al., 1996; Coor-
sen et al., 1996; Ninomiya et al., 1996). Capacitance mea-
surements indicated that exocytic vesicles mobilized by
low micromolar free Ca
 
2
 
1
 
 concentrations ([Ca
 
2
 
1
 
])
 
1
 
 in
CHO cells are large, with diameters between 0.4 and 1.5
 
m
 
m (Ninomiya et al., 1996). This size range is compatible
with the dimensions of mammalian lysosomes, which were
shown, in a number of different assays, to undergo exocy-
 
tosis in several cell lines when the intracellular [Ca
 
2
 
1
 
] is
elevated to 1–5 
 
m
 
M (Rodríguez et al., 1997). A similar
population of large vesicles capable of Ca
 
2
 
1
 
-regulated
exocytosis was also detected by patch clamp studies in
PC12 cells (Kasai et al., 1999), and by a combination of
patch clamp and amperometry in chromaffin cells (Xu et
al., 1998). Thus, it is becoming apparent that Ca
 
2
 
1
 
-regu-
lated secretion may be a property of all lysosomes, and not
only of the lysosome-like granules of hemopoietic cells, as
previously believed (Stinchcombe and Griffiths, 1999).
The low micromolar [Ca
 
2
 
1
 
] range in which lysosome
exocytosis takes place suggests that a high affinity Ca
 
2
 
1
 
sensor might be present on lysosomal membranes. Al-
though a number of Ca
 
2
 
1
 
-binding proteins have been
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suggested to act as Ca
 
2
 
1
 
 sensors in regulated exocytosis
(Burgoyne and Morgan, 1998), extensive genetic and func-
tional evidence is available only for synaptotagmin (Syt) I,
a synaptic vesicle transmembrane protein implicated in
the regulation of neurotransmitter release (Sudhof and
Rizo, 1996). Interactions with members of the exocytic
machinery including the SNAREs (soluble 
 
N
 
-ethylmale-
imide-sensitive factor [NSF] attachment protein recep-
tors), SNAP-25 and syntaxin, the soluble factors 
 
b
 
-SNAP
and NSF, in addition to Ca
 
2
 
1
 
 channels and phospholipids,
have contributed to the notion that Syt I may function by
modulating assembly of the membrane fusion complex
(Schiavo et al., 1998).
Recently, however, a more complex picture regarding
the role of Syts as Ca
 
2
 
1
 
 sensors has emerged. This family
has at least twelve identified isoforms, all of which have
unique NH
 
2
 
-terminal ecto domains, and a highly con-
served cytosolic domain containing the two Ca
 
2
 
1
 
-binding
C
 
2
 
 domains (C
 
2
 
A and C
 
2
 
B; Schiavo et al., 1998). The C
 
2
 
A
domain of Syt IV, which does not appear to bind Ca
 
2
 
1
 
(von Poser et al., 1997), is nonetheless an effective inhibi-
tor of Ca
 
2
 
1
 
-mediated synaptic vesicle exocytosis (Thomas
et al., 1999). Recent observations indicate that Syt IV
forms hetero-oligomers with Syt I on the membrane of
synaptic vesicles, an event that modulates the efficiency of
Ca
 
2
 
1
 
-secretion coupling (Littleton et al., 1999).
Most Syt isoforms identified so far are expressed pre-
dominantly in neuronal tissue, although the messages for
several of them can be detected at low levels elsewhere
(Butz et al., 1999). Syt I and II, the two major Syt isoforms
in brain, are abundant transmembrane proteins of synaptic
vesicles (Sudhof and Rizo 1996). Very little is known,
however, about the subcellular localization of the addi-
tional isoforms. Syt III, the third most abundant Syt in
brain, is enriched in synaptic plasma membranes (Butz et
al., 1999), and it was also reported to be present on secre-
tory granules of pancreatic 
 
b
 
-cells (Mizuta et al., 1997).
The latter localization study, however, used antibodies
raised against recombinant Syt III including the highly
conserved cytosolic domain, and such antibodies can
cross-react with other Syt isoforms (Butz et al., 1999).
Three Syt isoforms, VI, VII, and VIII, are expressed at sig-
nificant levels in several tissues, and thus have been desig-
nated the ubiquitously expressed members of the Syt fam-
ily (Li et al., 1995; Craxton and Goedert, 1999). No
subcellular localization information is available for Syt VI
and Syt VIII, except that in brain, Syt VI appears not to be
present in synaptic vesicles (Butz et al., 1999). In vitro
binding studies performed with recombinant proteins re-
vealed that Syt VI and Syt VIII do not exhibit Ca
 
2
 
1
 
-
dependent binding to either phospholipids or to syntaxin.
On the other hand, Ca
 
2
 
1
 
-dependent binding to syntaxin
was detected with Syt VII, and, interestingly, the [Ca
 
2
 
1
 
]
range required for this interaction was found to be in the
low micromolar range (Li et al., 1995). Thus, we decided
to further investigate Syt VII as a candidate for involve-
ment in the exocytosis of lysosomes, an event that occurs
in many cell types when the intracellular [Ca
 
2
 
1
 
] is elevated
above 1 
 
m
 
M (Rodríguez et al., 1997). The data presented
here are consistent with a role for the ubiquitously ex-
pressed Syt VII in the Ca
 
2
 
1
 
-regulated exocytosis of con-
ventional lysosomes.
 
Materials and Methods
 
Antibodies
 
Polyclonal antibodies against the NH
 
2
 
-terminal domain of Syt VII were
generated by immunizing a rabbit with the synthetic peptide MYRD-
PEAASPGAC cross-linked to keyhole limpet hemocyanin using Sulfo-
SMCC (Pierce Chemical Co.). Purified rabbit IgG (20 
 
m
 
g/ml) was pre-
incubated with 1.5 mg/ml of the peptides MYRDPEAASPGAC or
MAYAPREAGPDSC (scrambled control). A rabbit was immunized with
 
Escherichia coli
 
-expressed Syt VII C
 
2
 
A and the antibodies were affinity-
purified on affigel 10 coupled to Syt VII C
 
2
 
A (BioRad). E41120 mAbs to
EEA1 were obtained from Transduction Laboratories. The following ad-
ditional antibodies were provided as gifts: rabbit anti-rab 7 by Susanne
Pffefer (Stanford University, Stanford, CA) and C. Roy (Yale University,
New Haven, CT); rabbit anticalnexin by A. Helenius (ETHZ, Switzer-
land); rabbit anticathepsin L by D. Portnoy (University of California,
Berkeley, CA); rabbit anti-Syt I NH
 
2
 
-terminal peptide (MC17) by P. De
Camilli, (Yale University); mouse anti-Lgp120 LYIC6 mAb by I. Mell-
man (Yale University).
 
Subcellular Fractionation, Immunoprecipitation, and 
Western Blot
 
Normal rat kidney (NRK) cells plated 48 h before were scraped from the
dish and homogenized in 1 ml buffer H (10 mM triethanolamine, 10 mM
acetic acid, 1 mM EDTA, and 250 mM sucrose) by four passages in a ball
bearing homogenizer. A postnuclear supernatant was prepared and top
loaded on a 25% Percoll/20 mM sucrose density gradient solution prepared
in buffer H. Centrifugation was carried out at 4
 
8
 
C in a 70.1 TI fixed-angle
rotor and a Beckman L-80 centrifuge for 90 min at 18,000 
 
g
 
. Fractions were
collected from the bottom of the gradient, centrifuged for Percoll removal,
and concentrated with a centricon filter (Amicon) after solubilizing mem-
branes in 1% NP-40. Total cell extracts of NRK, L6E9 rat myoblasts, and L
mouse fibroblasts were obtained by solubilizing cells in 1 ml 150 mM NaCl,
50 mM Tris, pH 8.6, and 1% NP-40 containing protease inhibitors. For im-
munoprecipitation, 0.8 ml of NRK cell or rat brain lysates (containing 0.2
mg of protein) were mixed with 0.8 ml Tris 100 mM, pH 8.0, NaCl 10 mM,
and EDTA 10 mM, and incubated overnight at 4
 
8
 
C with 80 
 
m
 
g of preim-
mune or affinity-purified anti-Syt VII C
 
2
 
A rabbit IgG. Protein A–Seph-
arose beads were then added and the mixture was rotated for 2 h at room
temperature. After four washes with Tris 100 mM, pH 8.0, NaCl 10 mM,
EDTA 10 mM, 1 mg/ml BSA, and 0.05% NP-40, immunoprecipitated pro-
teins were eluted in SDS-PAGE sample buffer. After SDS-PAGE, pro-
teins were transferred to immobilon filters and blots were probed with an-
tibodies followed by ECL (New England Nuclear) detection.
 
Immunofluorescence and Endocytic
Tracer Internalization 
 
NRK cells were incubated with Texas red-conjugated 10,000 Mw dextran
(Molecular Probes) at 0.5 mg/ml for 3 h at 37
 
8
 
C, followed by extensive
washing and a 3-h chase in DME 10% FBS, followed by fixation in 2%
paraformaldehyde (PFA). For immunofluorescent detection of the ec-
todomain of Syt VII, cells were fixed and permeabilized by 10 min incu-
bation in 100% methanol at 
 
2
 
20
 
8
 
C, rehydrated in PBS for 30 min, incu-
bated with 10 
 
m
 
g/ml anti-Syt VII rabbit IgG containing 1 mM Syt VII
NH
 
2
 
-terminal peptide, the scrambled control peptide, or with anti-EEA1
mouse mAbs, followed by fluorescein-conjugated secondary antibodies.
For staining with anti-Syt VII C
 
2
 
A antibodies, cells were fixed in 2% PFA
and permeabilized for 2 min in 0.1% Triton X-100. Rat Lgp120 was de-
tected with the LYIC6 mAb in PFA-fixed cells permeabilized with 0.01%
saponin, and rab 7 was detected with affinity-purified rabbit anti-rab 7
IgG in PFA-fixed cells permeabilized with 0.5% saponin. For transferrin
detection, cells were incubated for 1 h at 37
 
8
 
C with 50 
 
m
 
g/ml Texas red or
25 
 
m
 
g/ml HRP-conjugated transferrin, followed by fixation. Peroxidase
activity on the plasma membrane was abolished by incubation of cultures
with MESNA for 10 min at 4
 
8
 
C before cell homogenization.
Fluorescence images were acquired in a Zeiss axiovert 135 microscope
with an Orca II digital camera (Hamamatsu) controlled by MetaMorph
software (Universal Imaging). 
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BSA-Gold Labeling of Lysosomes and
Electron Microscopy
 
Lysosomes were loaded with BSA absorbed to 5-nm gold particles for 3 h,
followed by a 3-h chase in DME 10% FBS at 37
 
8
 
C. Cells were fixed in 4%
PFA/0.5% glutaraldehyde in 200 mM Hepes buffer, pH 7.2, scraped from
the dish, pelleted, and embedded in 10% gelatin. Embedded pellets were
infiltrated with 2.1 M sucrose in PBS, frozen by immersion in liquid nitro-
gen and cryosectioned. Thawed sections were labeled with anti-Syt VII
rabbit IgG followed by a 10-nm protein A gold probe (from the Depart-
ment of Cell Biology, University of Utrecht, The Netherlands).
 
Expression and Purification of Recombinant
Syt Constructs 
 
To obtain the Syt VII gene, the oligonucleotide primers: 5
 
9
 
-CTCGAAT-
TCATGTACCGGGACCCGAGGCG-3
 
9
 
 (forward) and 5
 
9
 
-CTCGAAT-
TCGGCTTTCAGCTGGTGCCACTG-3
 
9
 
 (reverse) containing EcoRI
sites (underlined) were used to amplify cDNA synthesized from 10 
 
m
 
g of
total NRK cell RNA. The amplification product (1.2 Kb) was cloned into
the TA vector pCR2.1 (Invitrogen), and checked by sequencing. The Syt I
(obtained from P. De Camilli, Yale University, New Haven, CT) and Syt
VII genes were subcloned into the pET19b vector (Novagen) at the Xho
restriction site and expressed as a NH
 
2
 
-terminal polyhistidine-tagged fu-
sion proteins in
 
 Escherichia coli
 
 BL21 and purified on nickel-agarose, ac-
cording to the manufacturer’s instructions (Novagen).
To clone the C
 
2
 
A and C
 
2
 
B domains of Syt VII, the following primers
were used for PCR using Syt VII DNA as template: 5
 
9
 
-CTCCTCGAG-
AGCCGAGAGAACCTG-3
 
9
 
 (forward) and 5
 
9
 
-CTCCTCGAGATCGC-
TGCATGGCTTC-3
 
9
 
 (reverse) for the C
 
2
 
A domain and 5
 
9
 
-CTCCTC-
GAGATGGGAGTGGGAGCCGAG-3
 
9
 
 (forward) and 5
 
9
 
-CTCCTCG-
AGGGCTTTCAGCTGGTGCCACTG (reverse) for the C
 
2
 
B domain
(underlined sequence represents the XhoI site). Equivalent primers de-
signed based on the Syt I sequence were used for PCR using Syt I cDNA
as template. PCR products were purified, digested with XhoI, cloned into
pET19b, and used for expression and purification of the protein domains.
The correct size of the fragments was checked by SDS-PAGE (see Fig. 5 a).
For construction of a Syt VII–GFP chimera, the Syt VII gene was sub-
cloned into the EcoRI–KpnI site of the GFP expression vector, pEGFP-
N2 (Clontech), and transfections were done using FuGENE 6 (Boeh-
ringer Mannheim Corp.) according to manufacturer’s instructions.
 
Streptolysin O (SLO) Permeabilization,
 
b
 
-Hexosaminidase Secretion, and Lgp120 Surface 
Translocation Assays
 
Confluent monolayers of NRK cells were washed twice with 1 ml ice-cold
buffer A (20 mM Hepes, 110 mM NaCl, 5.4 mM KCl, 0.9 mM Na
 
2
 
HPO
 
4
 
,
10 mM MgCl
 
2
 
, 2 mM CaCl
 
2
 
, and 11 mM glucose, pH 7.4) and incubated
for 5 min at 4
 
8
 
C with SLO (Murex) at 0.5 U/ml in buffer A. After one
wash with 1 ml ice-cold buffer B (20 mM Hepes, 100 mM K-glutamate, 40
mM KCl, and 5 mM EGTA, pH 7.2), and 0.5 ml of buffer B containing 2
mM ATP and 5 mM free Mg
 
2
 
1
 
 (added as MgCl
 
2
 
) with or without Ca
 
2
 
1
 
 (fi-
nal [Ca
 
2
 
1
 
] 1 
 
m
 
M), and containing antibodies or recombinant Syt C
 
2
 
 frag-
ments, was added to the cells at 378C for the indicated time points. The de-
sired concentrations of free Mg21 and Ca21 were obtained with a Ca21 or
Mg21/EGTA buffering system calculated using the software by Foehr and
Warchol. Cell extracts were obtained by solubilization in buffer B 1% NP-
40, followed by centrifugation at 11,000 g. For detection of b-hexosamini-
dase activity, 350 ml was incubated for 15 min at 378C with 50 ml of 6
mM 4-methyl-umbellyferyl-N-acetyl-b-D-glucosaminide in sodium ci-
trate-phosphate buffer, pH 4.5. The reaction was stopped by addition of
100 ml of 2 M Na2CO3, 1.1 M glycine, and the fluorescence was measured
in a F-2000 spectrofluorimeter (Hitachi Instruments, Inc.) at excitation
365 nm, emmision 450 nm.
For detection of surface-translocated Lgp120, NRK cells plated on
glass coverslips were permeabilized with SLO as described above and ex-
posed to 100 ml of 1 mM Ca21 buffer containing antibodies or recombinant
Syt C2A fragments for 10 min at 378C. Cells were then incubated for 30
min at 48C with culture supernatant from a mouse hybridoma line
(Ly1C6) producing antibodies to rat Lgp120, washed with PBS at 48C, and
fixed with 2% PFA  for 15 min. After fluorescent staining with DAPI (for
detection of cell nuclei) and a goat anti–mouse IgG conjugate (for detec-
tion of the anti-Lgp120 mAb), coverslips were examined under a Zeiss ax-
iovert 135 fluorescence microscope.
Results and Discussion
Syt VII Is Localized on Mature, Dense Lysosomes of 
NRK Cells
The cytosolic COOH-terminal domains of Syts show a high
degree of similarity, but their short intralumenal NH2-ter-
minal domains are isoform-specific. This allowed us to
generate antibodies specific for Syt VII by immunizing
rabbits with a synthetic peptide corresponding to the
twelve NH2-terminal amino acids of rat Syt VII (MYRD-
PEAASPGA; Li et al., 1995) coupled to keyhole limpet
hemocyanin. Immunofluorescence of permeabilized NRK
cells revealed that these antibodies recognize a population
of intracellular vesicles in the presence of a scrambled con-
trol peptide (Fig. 1 a), but not of the correctly oriented Syt
VII NH2-terminal peptide (Fig. 1 b). Specific label with
anti-Syt VII antibodies was also observed by immunoelec-
tron microscopy on electron-dense vesicles containing in-
ternalized BSA-gold complexes chased for several hours
(Fig. 1 c). Anti-Syt VII antibodies also colocalized with
fluorescent dextran chased into late endocytic compart-
ments (Fig. 1, e–f). Syt VII-containing compartments did
not colocalize with the early endosome markers EEA1
(Simonsen et al., 1998; Fig. 1, g–i) or transferrin (not
shown).
On Western blots, the rabbit anti-Syt VII NH2-terminal
antibodies specifically recognized a band of z66 kD on ex-
tracts of NRK fibroblasts and L6E9 rat myoblasts, and
also reacted with recombinant Syt VII expressed in E. coli
(Fig. 2 a, left and middle). Recombinant, his-tagged Syt
VII migrated as an z48-kD band, as predicted from the
403 amino acid Syt VII sequence (Li et al., 1995) without
any posttranslational modifications. The MC17 antibody
specific for the Syt I NH2-terminal domain did not react
with NRK or L6E9 cells, but clearly recognized an z65-
kD band in rat brain extracts, and also the recombinant
Syt I expressed in E. coli, which, similarly to Syt VII, mi-
grates faster than the native protein on SDS-PAGE (Fig. 2
a, right). These results are thus consistent with the previ-
ously reported synaptic localization of Syt I and the ubiq-
uitous expression of Syt VII, and demonstrate that the an-
tibodies used in this study are isoform-specific. The lack of
detection of Syt VII in brain in this experiment reflects the
small amount of extract analyzed (see Fig. 4 d). As further
discussed below, this observation most probably reflects
the fact that brain preparations are enriched in nerve ter-
minals, and thus in Syt I-containing synaptic vesicles.
The colocalization of Syt VII with endocytic tracers
chased for several hours into NRK cells (Fig. 1, c–f) sug-
gested that this isoform was present on either late endo-
somes or lysosomes. To clarify this issue, we performed
subcellular fractionation of NRK cells on Percoll density
gradients under conditions that separate dense lysosomes
from late endosomes (Green et al., 1987; Czekay et al.,
1997). As shown in Fig. 2 a, the lysosomal enzyme b-hex-
osaminidase was enriched in high density fractions, whereas
Golgi and early endosome markers were detected in lower
density fractions. Western blot detection of additional
markers (Fig. 2 b) showed that the early endosome protein
EEA1 and the late endosome marker rab 7 (Feng et al.,
1995) were also present in low density fractions. The ERThe Journal of Cell Biology, Volume 148, 2000 1144
marker, calnexin (Hebert et al., 1995), showed a more
spread distribution, but it was absent from the higher den-
sity fractions. Antibodies to cathepsin L detected the un-
processed 36 kD form of the enzyme in low density frac-
tions of the gradient, whereas the lysosomally processed 28
and 21 kD forms (Portnoy et al., 1986) were, as expected,
present only in the high density fractions containing ma-
ture lysosomes. Anti-Syt VII antibodies reacted with a
z66 kD band on the same high density gradient fractions
containing the lysosomally processed forms of cathepsin L
(but not rab 7), and the labeling was specifically inhibited
by the Syt VII NH2-terminal peptide. Our results thus sug-
gest that Syt VII is localized on dense, mature lysosomes
of NRK fibroblasts.
GFP-tagged Syt VII Is Targeted to Lgp120-positive,
rab 7-negative Compartments
The lysosomal localization of Syt VII was confirmed by
expression of a GFP-tagged Syt VII construct in NRK
cells. Cells expressing relatively low amounts of GFP were
chosen for analysis, to avoid possible mislocalization due
to overexpression. Syt VII–GFP (COOH-terminal fusion)
was targeted to vesicles that colocalize with the lysosomal
Figure 1. Syt VII is localized on late endocytic compartments of NRK cells. a, Immunofluorescence with anti-Syt VII antibodies in the
presence of scrambled control peptide. b, Same as a, in the presence of Syt VII NH2-terminal peptide. c, Transmission EM of cryosec-
tions labeled with anti-Syt VII antibodies. Arrowheads point to 10-nm gold particles at the antibody binding sites; the arrow points to
internalized BSA-gold complexes. Bar, 0.5 mm. d, Anti-Syt VII immunofluorescence. e, Dextran-Texas red chased into late endocytic
compartments. f, Overlay of d and e. g, Anti-Syt VII immunofluorescence. h, Anti-EEA1 immunofluorescence. i, Overlay of g and h.
Arrowheads in d–f point to examples of colocalization between Syt VII and dextran-Texas red. The large spots over the nucleus reac-
tive with anti-Syt VII antibodies in d are artifacts of the methanol fixation.Martinez et al. Synaptotagmin VII Regulates Lysosome Exocytosis 1145
membrane glycoprotein, Lgp120 (Fig. 3, a–c), and with in-
ternalized dextran-rhodamine chased for several hours
(not shown). The Syt VII–GFP-containing compartments
did not colocalize with transferrin (Fig. 3, d–f) or EEA1
(not shown). The great majority of Syt VII–GFP-contain-
ing compartments also did not stain with antibodies
against the late endosome marker, rab 7 (Fig. 3, g–i).
These findings are consistent with the subcellular fraction-
ation data discussed above, which showed that endoge-
neous Syt VII is exclusively localized on dense organelles,
whereas the early and late endosome markers, EEA1 and
rab 7, are detected only on lighter density fractions (Fig.
2). Our observations thus suggest that Syt VII contains
specific targeting signals for dense, mature lysosomes of
NRK cells, and that these signals are distinct from the tar-
geting information present in Syt I, which is expressed on
the plasma membrane when transfected into CHO fibro-
blasts (Feany and Buckley, 1993; Feany et al., 1993).
The C2A Domain of Syt VII Regulates Ca21-triggered 
Exocytosis of Lysosomes
Extensive evidence implicating Syt C2A and C2B domains
in Ca21-triggered exocytosis was obtained through inhibi-
tion of exocytosis after introduction of specific peptides,
soluble recombinant fragments, or antibodies into neurons
(Bommert et al., 1993; Elferink et al., 1993; Mikoshiba et
al., 1995; Mochida et al., 1997) or certain endocrine cells
(Lang et al., 1997; Mizuta et al., 1997; Ohara-Imaizumi et
al., 1997). We took a similar approach to investigate the
role of the C2 domains of Syt VII on Ca21-regulated exo-
cytosis of lysosomes in NRK fibroblasts. Initially, a poly-
clonal rabbit antiserum was produced by imunization with
the purified recombinant C2A domain of Syt VII. The an-
tibodies were affinity-purified, and shown by Western blot
to recognize an z66-kD band in rat NRK and mouse L
fibroblast cell extracts, which comigrates with the
band  recognized in NRK fibroblasts and L6E9 myoblasts
by the antibodies against the Syt VII NH2 terminus pep-
tide (Fig. 4 a).
On immunofluorescence assays with NRK cells, the
anti-C2A antibodies labeled a vesicular population that
also contained the lysosomal glycoprotein, Lgp120 (Fig. 4
b). To confirm that these anti-Syt VII C2A antibodies re-
acted with the same molecule recognized by the anti-Syt
VII NH2 terminus antibodies, immunoprecipitation was
performed, followed by Western blot. NRK cell (Fig. 4 c,
NRK) or rat brain extracts (Fig. 4 c, Brain) were immuno-
precipitated with purified preimmune (Fig. 4 c, PI) or anti-
C2A (Fig. 4 c, a-C2A) IgG. The immunoprecipitates were
then run on SDS-PAGE, together with samples of NRK or
brain extracts, and processed for Western blot detection
with anti-Syt VII or anti-Syt I NH2-terminal antibodies.
Since all antibodies used in this experiment were gener-
ated in rabbits, the Western blot also revealed the heavy
chain of rabbit IgG, migrating at z55 kD. It is evident
from Fig. 4 c that the preimmune antibodies, although
loaded in higher amounts than the immune IgG, did not
immunoprecipitate Syt VII or Syt I. On the other hand,
Syt VII was clearly detected migrating above the IgG
heavy-chain band, after immunoprecipitation of NRK ex-
tracts with anti-C2A antibodies. Smaller amounts of Syt
VII were also detected after immunoprecipitation of brain
extracts with anti-C2A antibodies (Fig. 4 c, top). Although
Syt I was clearly detected on whole brain extracts, it was
not immunoprecipitated by the anti-C2A antibodies (Fig. 4
c, bottom). These results demonstrate that Syt VII is effec-
tively recognized in NRK cells by the antibodies generated
Figure 2. Syt VII colocalizes with dense lysosomes on subcellular
fractionation. a, Western blot of NRK fibroblasts, L6E9 myo-
blasts, and rat brain extracts (5 mg/lane), and recombinant Syt
VII (rSyt VII) with anti-Syt VII antibodies in the presence of the
scrambled control peptide (left), or in the presence of the NH2-
terminal Syt VII peptide (center). Right, Western blot with anti-
bodies to Syt I (MC17) of the same extracts, and recombinant Syt I
(rSyt I). b, Percoll density gradient fractionation of NRK cells.
Top, detection of b-hexosaminidase, mannosidase II, and trans-
ferrin–HRP on gradient fractions collected from the bottom (ac-
tivities assayed using 4-methyl-umbellyferyl-N-acetyl-b-D-glu-
cosaminide, 4-methylumbelliferyl a-D-mannopyranoside, and 3,39,
5,59-tetramethylbenzidine as substrates, respectively). Bottom,
Western blot detection of Syt VII, cathepsin L, rab 7, EEA1, and
calnexin on gradient fractions.The Journal of Cell Biology, Volume 148, 2000 1146
against the Syt VII C2A domain, and suggest that these an-
tibodies do not cross-react with the C2A domain of Syt I.
Again, similarly to what is shown in Fig. 2 a, Syt VII was
not detected in 5 mg of rat brain extract, whereas it was
clearly detected on the same amount of NRK cell extract
(Fig. 4 c, top).
Previous studies established the predominantly neu-
ronal expression of Syt I, and the ubiquitous distribution
of Syt VII (Li et al., 1995; Sudhof and Rizo, 1996). There-
fore, it was initially puzzling to us the lack of detection of
Syt VII in rat brain, particularly in view of reverse tran-
scriptase (RT)-PCR and Western blot data that suggested
a higher expression of Syt VII in brain than in other tissues
(Li et al., 1995). To clarify this issue, we performed West-
ern blots on increasing amounts of NRK or rat brain ex-
tracts, with the antibodies specific for the NH2 terminus of
Syt VII or Syt I. As shown in Fig. 4 d, top, Syt VII was only
detected in brain when about eight times more material
was loaded in the gels. Syt I, as expected, was detected in
all concentrations of brain extract, but not in NRK cells
(Fig. 4 d, bottom). These results reinforce our interpreta-
tion that this effect is due to the lower abundance of lyso-
somes in relation to synaptic vesicles in brain extracts. It is
important to note that our experiments involved highly
specific antibodies against the unique ectodomain of Syt
VII, which exclusively detect full-length, transmembrane
Syt VII. Li et al. (1995), on the other hand, generated anti-
bodies against the cytosolic region of Syt VII containing
the conserved C2 domains, which, in addition to a possible
cross-reactivity with other isoforms (Butz et al., 1999), do
not distinguish between full-length and truncated forms
generated by alternative splicing. A recent study reported
that the vast majority of RT-PCR products of Syt VII ob-
tained from rat brain lacked the transmembrane region,
apparently due to exon skipping. Importantly, that study
also showed that all the exon-skipped forms of Syt ob-
Figure 3. Transfected Syt VII-GFP is targeted to mature lysosomes of NRK cells. a, Syt VII-GFP. b, Anti-Lgp120 immunofluorescence.
c, Overlay of a and b. d, Syt VII-GFP. e, Transferrin/Texas red-containing early endosomes. f, Overlay of d and e. g, Syt VII-GFP. h,
Anti-rab 7 immunofluorescence. i, Overlay of g and h.Martinez et al. Synaptotagmin VII Regulates Lysosome Exocytosis 1147
tained by RT-PCR resulted in frame-shifted messages
(Craxton and Goedert, 1999). This implies that the origi-
nal NH2-terminal sequence of Syt VII would not be
present in the truncated forms, explaining the lack of reac-
tivity with our antibodies generated against the NH2-ter-
minal sequence of full-length Syt VII. It was suggested
that unknown upstream exons may import novel NH2-ter-
minal sequences to these exon-skipped forms, or, alterna-
tively, that frame-shifted forms may be initiated down-
stream, to produce double C2 domain-containing proteins
(Craxton and Goeder, 1999). Although the physiological
function of these truncated forms of Syt VII remains to be
determined, it is noteworthy that alternative splicing appears
to be a mechanism commonly used in the brain of higher or-
ganisms for increasing functional diversity (Black, 1998).
Having established that the anti-Syt VII C2A antibodies
recognize lysosome-associated Syt VII in NRK cells, b-hex-
osaminidase secretion assays (Rodríguez et al., 1997) were
performed to verify if the antibodies interfered with Ca21-
triggered lysosome exocytosis. When SLO-permeabilized
NRK cells were exposed to 1 mM [Ca21] in the presence of
5 or 12 mg/ml affinity-purified anti-Syt VII C2A antibodies,
inhibition levels of 46 and 87%, respectively, were ob-
served in relation to the level of b-hexosaminidase re-
leased in the presence of preimmune rabbit antibodies
(Fig. 5 a). Next, we followed the translocation of lysosomal
membrane proteins to the cell surface, as an additional as-
say to examine the inhibitory effect of the anti-Syt VII
C2A antibodies on Ca21-triggered lysosome exocytosis.
The antibodies generated against the Syt VII NH2 termi-
nus ectodomain peptide were not used for these surface-
labeling assays because they only recognize Syt VII in cells
fixed and permeabilized with methanol (possibly reflect-
ing a need to extract other lysosomal proteins to expose
the epitopes). Thus, we used the previously characterized
assay of Ca21-dependent surface translocation of the lu-
menal domain of Lgp120 (Rodríguez et al., 1997), which
colocalizes with Syt VII in NRK cells (Fig. 3, a–c). The
cells were permeabilized with SLO, exposed to buffer con-
taining or not 1 mM Ca21 and 12 mg/ml preimmune IgG or
anti-Syt VII C2A affinity-purified antibodies, and surface-
labeled at 48C with an mAb against a lumenal domain
epitope of Lgp120. As shown in Fig. 5, b–e, 1 mM Ca21
triggers the translocation of Lgp120 to the plasma mem-
brane of SLO-permeabilized NRK cells, resulting in a
punctate surface fluorescence pattern identical to that pre-
viously reported for ionomycin-treated intact NRK cells
(Rodríguez et al., 1997). When the cells were exposed to
Ca21 in the presence of anti-Syt VII C2A antibodies, a sig-
nificant reduction in surface-exposed Lgp120 was ob-
served (Fig. 5, f–g).
These findings strongly suggested a functional role for
the C2A domain of Syt VII in the regulation of lysosome
exocytosis. To confirm these results, we proceeded to ver-
ify, using the two assays described above, if introduction of
soluble Syt C2 domains had a specific and direct effect on
lysosome exocytosis. Histidine-tagged C2A, C2B, or C2A–
C2B domains of Syt VII and of the exclusively neuronal
isoform Syt I were expressed in E. coli and purified (Fig. 6
a). NRK cells were permeabilized and exposed to Ca21 for
10 min in the presence of increasing concentrations of the
Syt VII C2A domain, and the supernatant was assayed for
released b-hexosaminidase. A clear dose-dependent inhi-
bition in exocytosis was observed, reaching 90% at 200 mg/
ml. The same concentrations of the Syt I C2A domain had
no effect (Fig. 6 b).
Kinetic  b-hexosaminidase secretion assays were then
performed in the presence of 200 mg/ml recombinant Syt I
Figure 4. Specificity of the
antibodies generated against
the NH2-terminal and C2A
domains of Syt VII. a, West-
ern blot of NRK or L mouse
fibroblast extracts (5 mg/lane)
with antibodies to Syt VII
NH2 terminus peptide (a-Syt
VII) or to Syt VII recombi-
nant C2A domain (a-C2A). b,
Immunofluorescence of NRK
cells with anti-Syt VII C2A
antibodies (left) or anti-
Lgp120 (right). c, Immuno-
precipitation of NRK or rat
brain extracts with anti-Syt
VII C2A antibodies, Western
blotted with antibodies to the
NH2 terminus of Syt VII
(top) or Syt I (bottom). Syt
indicates the position of Syt
VII or Syt I, and IgG the po-
sition of the heavy chain of
rabbit IgG. E, Total extract;
PI,  immunoprecipitate ob-
tained with preimmune rabbit IgG; a-C2A, immunoprecipitate with anti-Syt VII C2A affinity-purified IgG. d, Western blot of increas-
ing amounts of NRK (10 or 20 mg) or rat brain (5–40 mg) extracts with antibodies against the NH2 terminus of Syt VII (top) or Syt I
(bottom).The Journal of Cell Biology, Volume 148, 2000 1148
and Syt VII C2A, C2B, and C2A–C2B fragments. No inhi-
bition was observed with the C2A or C2B domains of Syt I,
and only a partial reduction (of z30%) in b-hexosamini-
dase release was detected in the presence of the larger Syt
I fragment containing both the C2A and C2B domains
(Fig. 5 c). In contrast, a strong inhibition, detectable after
the initial five minutes, was observed in the presence of
both constructs containing the Syt VII C2A domain (Fig. 6
d). Only a small reduction in exocytosis (of ,20%) was
detected at the later time points in the presence of the Syt
VII C2B domain alone. An unrelated protein (OP-Tc), ex-
Figure 5. Antibodies against the Syt VII C2A domain inhibit ly-
sosome exocytosis in NRK cells. a, Cells were permeabilized with
SLO, stimulated or not with 1 mM Ca21 in the presence of the in-
dicated concentrations of preimmune rabbit IgG or anti-Syt VII
C2A, and the supernatant was assayed after 10 min for released
b-hexosaminidase. b, Surface immunofluorescence of Lgp120 in
SLO-permeabilized cells in the absence of Ca21. c, Same field as
b, DAPI stain of cell nuclei. d, Surface immunofluorescence of
Lgp120 in cells permeabilized in the presence of 1 mM Ca21 and
12 mg/ml rabbit preimmune antibodies. e, Same as d, DAPI stain.
f, Surface immunofluorescence of Lgp120 in cells permeabilized
in the presence of 1 mM Ca21 and 10 mg/ml anti-Syt VII C2A anti-
bodies. g, Same as f, DAPI stain.
Figure 6. Syt VII C2A domain inhibits lysosome exocytosis in
NRK cells. a, SDS-PAGE (10 mg/lane) of recombinant Syt VII
C2A (1); Syt VII C2B (2); Syt VII C2A-B (3); Syt I C2A (4); Syt I
C2B (5); and Syt I C2A-B (6). b, Permeabilized cells were stimu-
lated with 1 mM Ca21 in the absence or presence of the indicated
concentrations of Syt VII or Syt I C2A domains, and the superna-
tant was assayed after 10 min for released b-hexosaminidase. c,
Permeabilized cells were stimulated with Ca21 in the absence or
presence of 200 mg/ml Syt I fragments, and the supernatant was
assayed for released b-hexosaminidase at the indicated time
points. d, Same as c, except that 200 mg/ml Syt VII fragments
were used. Op-Tc (d) corresponds to an unrelated protein ex-
pressed in E. coli and purified under the same conditions. The
data is expressed as percentage of the total cellular content of
b-hexosaminidase (mean of triplicates 6 SD). e–h, Permeabi-
lized cells were stained for surface Lgp120 after incubation in
buffer containing: e, no Ca21; f, 1 mM Ca21; g, 1 mM Ca21 plus
200 mg/ml recombinant Syt I C2A fragments; and h, 1 mM Ca21
plus 200 mg/ml recombinant Syt VII C2A fragments.Martinez et al. Synaptotagmin VII Regulates Lysosome Exocytosis 1149
pressed and purified under the same conditions, had no ef-
fect (Fig. 6 d). Lgp120 surface-translocation assays con-
firmed the specific inhibitory effect of the Syt VII C2A
domain on lysosome exocytosis. Whereas the typical pat-
tern of Ca21-triggered Lgp120 surface immunofluores-
cence was observed in cells exposed or not to Syt I C2A
(Fig. 6, f–g), the presence of Syt VII C2A fragments was
strongly inhibitory (Fig. 6 h).
The results of these functional exocytosis assays suggest
a specific role for Syt VII in the regulation of Ca21-induced
lysosome exocytosis. In particular, our data points to the
involvement of C2A domain-specific functions of Syt VII,
which include the binding of syntaxin at low micromolar
[Ca21] (Li et al., 1995). Although our findings are consis-
tent with a function for Syt VII as a high affinity Ca21 sen-
sor, additional studies are needed to clarify the basis for
this activity, and to further characterize the structural and
functional differences between the C2 domains of different
Syt isoforms.
The presence of Syt VII on the membrane of dense lyso-
somes may explain earlier observations of assembly of
AP-2–containing clathrin coats on mature lysosomes of
permeabilized NRK cells (Traub et al., 1996). AP-2 has
been shown to bind to the C2B domain of Syt I (Zhang et
al., 1994) and several other Syt isoforms, including Syt VII
(Li et al., 1995; Haucke and De Camilli, 1999). It is thus
conceivable that Syt VII is also involved in the retrieval of
lysosomal components delivered to the plasma membrane
by exocytosis, in an analogous manner to the proposed
role of Syt I in synaptic vesicle recycling (Fukuda et al.,
1995; Jorgensen et al., 1995).
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